Sean Cunningham

Title: Sean Cunningham: Innovator in Pharmaceutical Composition

Introduction

Sean Cunningham is a notable inventor based in Athlone, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on aminopyridine compositions. His research focuses on developing effective treatments for various neurological diseases.

Latest Patents

Cunningham holds a patent for a "Sustained release aminopyridine composition." This pharmaceutical composition includes a therapeutically effective amount of aminopyridine dispersed in a release matrix. The formulation is designed to provide a stable, sustained-release oral dosage, such as a tablet, which maintains a therapeutically effective plasma level of aminopyridine for at least 12 hours, and preferably 24 hours or more. This innovation aims to enhance treatment options for patients suffering from neurological disorders.

Career Highlights

Sean Cunningham is currently employed at Alkermes Pharma Ireland Limited, where he continues to advance his research in pharmaceutical sciences. His work is characterized by a commitment to improving patient outcomes through innovative drug formulations.

Collaborations

Cunningham collaborates with esteemed colleagues, including Seamus Mulligan and Michael Myers, who contribute to the development and refinement of his pharmaceutical innovations.

Conclusion

Sean Cunningham's contributions to the field of pharmaceuticals, particularly through his patent on sustained release aminopyridine compositions, highlight his role as an innovator dedicated to improving treatments for neurological diseases. His work at Alkermes Pharma Ireland Limited and collaborations with fellow researchers further underscore his impact in the industry.